πŸ‡ΊπŸ‡Έ FDA
Patent

US 12017030

Hydrogen-enhanced transdermal system

granted A61KA61K47/02A61K9/0004

Quick answer

US patent 12017030 (Hydrogen-enhanced transdermal system) held by H2 Universe LLC expires Mon Jun 20 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
H2 Universe LLC
Grant date
Tue Jun 25 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 20 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K47/02, A61K9/0004, A61K9/0014, A61K9/7084